| Literature DB >> 33815601 |
Simona Pătru1, Rodica Pădureanu2, Florentina Dumitrescu3, Vlad Pădureanu4, Dumitru Rădulescu5, Diana Dragoi6, Daniela Matei1.
Abstract
There is no specific cure for fibromyalgia (FM), but combined non-pharmacologic and pharmacologic treatments may mitigate symptoms and improve quality of life in patients. The aim of the present study was to monitor patient response to several types of therapy, including cognitive-behavioral and occupational therapy, and kinetic therapy, as compared to a control group that was not subjected to any form of therapy. The study included 98 FM patients, all women, out of which 32 received cognitive-behavioral therapy and occupational therapy (CBT+OT), 34 kinetic therapy (KT) and 32 participated as controls. The evaluation protocol comprised two questionnaires developed in order to assess the patient's condition as fully as possible: Fibromyalgia Impact Questionnaire (FIQ) and Fibro Fatigue (FF) scale. At the pre-evaluation there were no significant inter-group differences. At post-evaluation significant differences were observed between the control sample and the group subjected to kinetic therapy (P<0.05). FIQ scores decreased in the CBT+OT group too, but less than that in the KT group. The FF scale registered notable evolutions in time for the group subjected to kinetic therapy. In order to control and improve most of the FM symptoms, besides proper medication, we suggest an interdisciplinary intervention mainly focusing on long-term individualized kinetic therapy. The simultaneous integration of a cognitive-behavioural and occupational therapy intervention could be the element that completes the complex treatment of FM patients. Copyright: © Pătru et al.Entities:
Keywords: cognitive-behavioral therapy and occupational therapy; fibromyalgia; kinetic therapy; non-pharmacologic treatment
Year: 2021 PMID: 33815601 PMCID: PMC8014964 DOI: 10.3892/etm.2021.9960
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
Clinical diagnosis data.
| Socio-demographic data Clinical data | CBT+OT (n=32) | Kinetic therapy (n=34) | Controls (n=32) |
|---|---|---|---|
| Age: mean ± SD | 52.4 (7.2) | 55.3 (7.2) | 56.3 (8.8) |
| Year of diagnosis: Mean ± SD | 2001.3 (7.5) | 2009.3(2) | 2003.6 (4.6) |
| Year of pain onset: Mean ± SD | 1995.7 (9.7) | 2000.8 (7.3) | 1990.7 (11.6) |
| Irritable bowel syndrome (%) | 53.5 | 23.5 | 29 |
| Chronic fatigue syndrome (%) | 74 | 20.6 | 63.3 |
| Tension headaches (%) | 73 | 52.9 | 77.4 |
| Endocrine disorders (%) | 44.8 | 41.2 | 25.8 |
| Rheumatic disorders (%) | 59.2 | 2.9 | 64.5 |
| Anxiety or depression (%) | 92.8 | 52.9 | 83.8 |
| Other associated conditions (%) | 45.4 | 55.8 | 45.4 |
th, therapy; n, number of patients; SD, standard deviation; CBT, cognitive-behavioral therapy; OT, occupational therapy.
Total FIQ scores.
| Group | FIQ total Pre | FIQ total Post | FIQ total follow-up |
|---|---|---|---|
| CBT+OT mean ± SD | 71 (15.9) | 62.6 (20.2) | 68.6 (15.7) |
| KT mean ± SD | 69.4 (16.1) | 50.8 (17.6) | 52.8 (17.9) |
| Controls mean ± SD | 74.3 (11.5) | 70.7 (15.9) | 68.9 (17.5) |
SD, standard deviation; FIQ, Fibromyalgia Impact Questionnaire; CBT, cognitive-behavioral therapy; OT, occupational therapy; KT, kinetic therapy.
Figure 1Scores of the Fibro Fatigue scale.